Adaptive clinical trials are increasingly being used to answer important healthcare questions. Basket and Umbrella trials have been used for some time in the cancer setting, while COVID-19 brought Platform trials into the limelight. There are many advantages to adaptive trial designs, however, there are also many important factors to be considered and significant expertise is required.
The visual and audio recording of the 2 hour information session covering statistical and trial design considerations of adaptive and platform clinical trials, as well as some trial examples is available in the link above.
Guest presenters: Associate Professor Liz Holliday, Professor Leonid Churilov, Professor Tom Snelling and Professor Steve Webb.
Chaired by Professor Mark Parsons and Professor Meera Agar. Organised by Dr Lucy Coupland. Thanks to Vanessa Moore for her assistance.
